Consistent with these results, genetic analysis of The Cancer Genome Atlas AML dataset by Chaudhry et al. demonstrated that GLI3 expression is epigenetically silenced in most AML patients [18]. The gene discussed is GLI3; the disease is acute myeloid leukemia.